INIS
diseases
100%
arteries
100%
people
62%
muscles
56%
performance
31%
nitric oxide
31%
therapy
18%
mitochondria
18%
mobility
12%
nitrites
12%
plasma
12%
damage
12%
ischemia
12%
losses
12%
distance
6%
doses
6%
pathology
6%
design
6%
fibers
6%
oxidation
6%
satellites
6%
comparative evaluations
6%
clinical trials
6%
repair
6%
quality of life
6%
control
6%
data
6%
blood flow
6%
injuries
6%
spin
6%
interventions
6%
proposals
6%
wavelengths
6%
angiogenesis
6%
nmr imaging
6%
patients
6%
humans
6%
hypothesis
6%
biological availability
6%
labelling
6%
biopsy
6%
molecules
6%
Medicine and Dentistry
Arteriosclerosis Obliterans
100%
Nitric Oxide
31%
Gastrocnemius Muscle
25%
Perfusion
25%
Skeletal Muscle
18%
Nitrite
12%
Plasma
12%
Therapeutic Procedure
12%
Older People
12%
Age
12%
Combination Therapy
6%
Non Invasive Procedure
6%
Bioavailability
6%
Chlormethine
6%
Phase II Trials
6%
Oxidative Stress
6%
Randomized Clinical Trial
6%
Quality of Life
6%
Muscle
6%
Arterial Spin Labeling
6%
Follow up
6%
Muscle Biopsy
6%
Blood Flow
6%
Single Drug Dose
6%
Species
6%
Muscle Disease
6%
Angiogenesis
6%
Biological Product
6%
Ischemia
6%
Gastrocnemius
6%
Perfusion Weighted Imaging
6%
Deterioration
6%
Satellite Cell
6%
Ischemic Injury
6%
Signaling Molecule
6%
Muscle Perfusion
6%
Phototherapy
6%
Muscle Injury
6%
Patient-Reported Outcome
6%
Health
6%
Biological Activity
6%
Functional Disease
6%